FDL169
| CAS No. | 1628416-28-3 | Cat. No. | BCP30546 |
| Name | FDL169 | ||
| Synonyms | FDL-169;FDL 169; | ||
| Formula | C27H23FN4O4 | M. Wt | 486.50 |
| Description | FDL169 is a drug being developed by Flatley Discovery Lab that is targeted for cystic fibrosis (CF) patients who carry the F508del mutation, the most common mutation in this disease. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | CFTR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.